Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1B | Q00975 | 14/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.42 |
| ▸ | CCR5 | P51681 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7350815 | 0.93 | CACNA1B (0.62) | CACNA1BLMNASMN1; SMN2ALOX5CCR5 | |
| SCHEMBL7354272 | 0.90 | CACNA1B (0.61) | CACNA1BMEN1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL7036883 | 0.87 | CACNA1B (0.60) | CACNA1BALOX5CCR5 | |
| SCHEMBL7354077 | 0.86 | CACNA1B (0.58) | CACNA1BMEN1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL7043414 | 0.85 | CACNA1B (0.61) | CACNA1BALOX5CCR5 | |
| SCHEMBL7359677 | 0.85 | CACNA1B (0.62) | CACNA1BMEN1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL7041055 | 0.85 | CACNA1B (0.57) | CACNA1BLMNASMN1; SMN2ALOX5CCR5 | |
| SCHEMBL7043419 | 0.84 | CACNA1B (0.69) | CACNA1B | |
| SCHEMBL7043714 | 0.84 | CACNA1B (0.56) | CACNA1BLMNASMN1; SMN2ALOX5CCR5 | |
| SCHEMBL7038421 | 0.84 | CACNA1B (0.60) | CACNA1BALOX5CCR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1999007689-A1 | ANILINE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS | WARNER-LAMBERT COMPANY (US) | 1999-02-18 | — | — | WO | claimed |